UCLA researchers in the Departments of Chemistry, Physics, and Bioengineering, led by Dr. Tim Deming of the Bioengineering department, have developed a platform to create and modify nanoscale particles and gels for use in the industrial biomaterials market. The polypeptide based delivery vehicle platforms created by the Deming group are customizable in nearly all physical characteristics, can be tailored in size, loaded with hydrophobic and hydrophilic payloads, used in coatings, are fully synthetic, possess highly reproducible properties, and are inexpensive to prepare compared to solid-phase peptide synthesis.The platform can be used to create novel, need-based nanoscale vesicles or injectable hydrogels, and can also be used to augment existing materials systems.
Advanced materials play a critical role within a variety of industries across the globe. From construction, utilities, transportation and logistics, food and beverage, cosmetics, telecommunications, electronics, oil and gas, petrochemicals, and packaging, industries are heavily investing in advanced materials to address their needs. For this reason, nanoscale technologies have received significant research and development over the past few years. These nanoscale systems offer the promise of stability, synthetic, reproducible, and low cost.
References: UCLA Cases 1998-072, 2001-307, 2007-014, 2008-767, 2012-598, 2013-315, 2015-124, 2015-452, 2015-612
Deming Group: http://deming.seas.ucla.edu/
For further information on this innovation, contact:Rick Clark